UY32289A - Tratamiento para la glomerulonefritis - Google Patents

Tratamiento para la glomerulonefritis

Info

Publication number
UY32289A
UY32289A UY0001032289A UY32289A UY32289A UY 32289 A UY32289 A UY 32289A UY 0001032289 A UY0001032289 A UY 0001032289A UY 32289 A UY32289 A UY 32289A UY 32289 A UY32289 A UY 32289A
Authority
UY
Uruguay
Prior art keywords
treatment
glomerulonefritis
glomerulonephritis
compound
formula
Prior art date
Application number
UY0001032289A
Other languages
English (en)
Inventor
Elizabeth M Allen
Dharanipragada Ramalinga
Gillespy Timothy
Oligino Thomas
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY32289A publication Critical patent/UY32289A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un tratamiento para la glomerulonefritis, y otras disfunciones renales, usando un compuesto de la Fórmula I.
UY0001032289A 2008-12-03 2009-12-03 Tratamiento para la glomerulonefritis UY32289A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11947608P 2008-12-03 2008-12-03

Publications (1)

Publication Number Publication Date
UY32289A true UY32289A (es) 2010-06-30

Family

ID=41571088

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032289A UY32289A (es) 2008-12-03 2009-12-03 Tratamiento para la glomerulonefritis

Country Status (16)

Country Link
US (1) US20110251219A1 (es)
EP (1) EP2373316A1 (es)
JP (1) JP2012510519A (es)
KR (1) KR20110117650A (es)
CN (1) CN102238952A (es)
AR (1) AR074437A1 (es)
AU (1) AU2009322478A1 (es)
BR (1) BRPI0922216A2 (es)
CA (1) CA2745199A1 (es)
IL (1) IL213287A0 (es)
MX (1) MX2011004789A (es)
PA (1) PA8851701A1 (es)
RU (1) RU2011127128A (es)
TW (1) TW201032810A (es)
UY (1) UY32289A (es)
WO (1) WO2010065571A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
WO2008033789A2 (en) * 2006-09-11 2008-03-20 Ticona Llc Method of measuring fiber length for long fiber reinforced thermoplastic composites

Also Published As

Publication number Publication date
RU2011127128A (ru) 2013-01-10
BRPI0922216A2 (pt) 2015-12-29
JP2012510519A (ja) 2012-05-10
PA8851701A1 (es) 2010-07-27
EP2373316A1 (en) 2011-10-12
TW201032810A (en) 2010-09-16
WO2010065571A1 (en) 2010-06-10
KR20110117650A (ko) 2011-10-27
CN102238952A (zh) 2011-11-09
CA2745199A1 (en) 2010-06-10
US20110251219A1 (en) 2011-10-13
AU2009322478A1 (en) 2011-06-23
IL213287A0 (en) 2011-07-31
AR074437A1 (es) 2011-01-19
MX2011004789A (es) 2011-05-30

Similar Documents

Publication Publication Date Title
CY1119515T1 (el) Οξαζολο υποκατεστημενα ινδαζολια ως αναστολεις ρι3-κινασης
UY32292A (es) Agonistas de s1p1 y métodos de preparación y uso
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
CR20120295A (es) Triazolopiridinas
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
UA107791C2 (en) Pesticidal compositions
MX2010002243A (es) Derivados fungicidas de 2-alquiltio-2-quinoliniloxi-acetamida.
CR20120348A (es) Nuevos compuestos tricíclicos
CR11776A (es) Inhibidores de bace
BRPI1012770B8 (pt) derivados de tiofeno
EA200900945A1 (ru) Новый способ синтеза агомелатина
EA201170154A1 (ru) Производные пиридинопиридинонов, способ их получения и применение в терапии
CR20110432A (es) Pirimidinas fusionadas
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
EA201200102A1 (ru) Соединения, применимые в качестве лекарственных средств
EA201101148A1 (ru) Новые гербициды
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
EA200900946A1 (ru) Новый способ синтеза агомелатина
EA201101146A1 (ru) Новые гербициды
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA201100920A1 (ru) Новые гербициды
EA201200498A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
EA201101097A1 (ru) Новые микробиоциды
CY1111573T1 (el) Νεα μεθοδος συνθεσης της αγομελατινης
EA200900944A1 (ru) Новый способ получения кристаллической формы v агомелатина

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140410